跳至主要内容
临床试验/CTRI/2024/03/064562
CTRI/2024/03/064562尚未招募2 期

A Pilot Study to evaluate the Clinical Efficacy of an Ayurvedic Treatment Module in the Management of Multiple Sclerosis ( Sarvanga Gatavata) - NI

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who are fit to undergo Snehapana, Virechana, Swedana,Basti and Nasya Karma.
  • 2.Diagnosed cases of Multiple Sclerosis with MRI , continuing allopathic medication and EDSS score less than 8.
  • 3. ICD code: G - 35
  • 4. Socio- economic status: All

排除标准

  • 1. Cardiac disease, pulmonary tuberculosis, severe lung disease, diabetes and pregnant women, exposed skin related disease.
  • 2.EDSS score more than 8 .

研究者

相似试验

Study to check the efficacy of Panchakarma... | 临床试验